IP Library Granted Patent US 11,584,950
Granted Patent B2
US 11,584,950 · App. 16/705,941 · Granted Feb 21, 2023

Methods and systems for detecting entities in a biological sample

Inventors: Joseph Joel Pollak (Neve Daniel, IL); Daniel Levner (Brookline, MA); Yonatan Bilu (Jerusalem, IL); Arnon Houri Yafin (Jerusalem, IL); Noam Yorav-Raphael (Tekoa, IL); Yuval Greenfield (Sunnyvale, CA)
Assignee: S.D. Sight Diagnostics Ltd.
C12Q1/68G01N1/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,584,950
App. No.
16/705,941
Granted
Feb 21, 2023
Kind
B2
Abstract

Apparatus and methods for use with a blood sample are described. The blood sample is stained with Hoechst stain and Acridine Orange stain. A plurality of images of the blood sample are acquired. An object is identified as being a white blood cell candidate. A first stained area, which is stained by the Hoechst stain and which is disposed within the white blood cell candidate, is identified. A second stained area, which is stained by the Acridine Orange stain and which is disposed within the white blood cell candidate, is identified. A white blood cell is detected by determining that structural features of the stained areas satisfy predetermined criteria associated with a white blood cell. Other applications are also described.

Claims (12)

1. A method for identifying a white blood cell within a blood sample, the method comprising:

staining the blood sample with at least a first dye that predominantly stains DNA, and a second dye that stains at least one other cellular component being different from DNA;

using a microscope, acquiring a plurality of images of the blood sample, at least one first one of the images being acquired while the blood sample is illuminated under brightfield conditions, at least one second one of the images being acquired while the blood sample is illuminated by a light source having an illumination wavelength that causes the first dye to fluoresce, and at least one third one of the images being acquired while the blood sample is illuminated by a light source having an illumination wavelength that causes the second dye to fluoresce; and

using at least one computer processor, identifying the white blood cell within the blood sample, by:

identifying an object within the plurality of images as being a white blood cell candidate, by analyzing the first one of the images;

identifying that a first stained area, which is stained by the first dye, is disposed within the white blood cell candidate, by analyzing the second one of the images;

identifying that a second stained area, which is stained by the second dye, is disposed within the white blood cell candidate, by analyzing the third one of the images; and

determining that one or more structural features of the first and second stained areas satisfy predetermined criteria associated with a white blood cell, the structural features comprising the sizes of the first and second stained area relative to a size of the identified object.

2. The method according to claim 1 , wherein identifying the white blood cell comprises distinguishing between the white blood cell and a pathogen.

3. The method according to claim 1 , wherein identifying the white blood cell comprises determining that sizes of the first and second stained areas are similar to that of the identified object.

4. The method according to claim 1 , wherein identifying the white blood cell comprises determining that sizes of the first and second stained areas are not substantially smaller than that of the identified object.

5. The method according to claim 1 , wherein staining the blood sample with the second dye comprises staining the blood sample with Acridine Orange.

Assignments (6)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 23, 2025
From: KREOS CAPITAL VII AGGREGATOR SCSP
To: S.D. SIGHT DIAGNOSTICS LTD.
Reel/Frame 069993/0260 →
SECURITY INTEREST Recorded Dec 7, 2023
From: S.D. SIGHT DIAGNOSTICS LTD
To: KREOS CAPITAL VII AGGREGATOR SCSP
Reel/Frame 065788/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 28, 2023
From: BANK LEUMI LE-ISRAEL B.M.
To: S.D. SIGHT DIAGNOSTICS LTD.
Reel/Frame 065673/0880 →
SECURITY INTEREST Recorded Jul 3, 2022
From: S.D. SIGHT DIAGNOSTICS LTD.
To: BANK LEUMI LE-ISRAEL B.M.
Reel/Frame 060393/0580 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2020
From: POLLAK, JOSEPH JOEL; LEVNER, DANIEL; BILU, YONATAN; YAFIN, ARNON; YORAV-RAPHAEL, NOAM; GREENFIELD, YUVAL
To: SIGHT DIAGNOSTICS LTD.
Reel/Frame 051938/0929 →
CHANGE OF NAME Recorded Feb 26, 2020
From: SIGHT DIAGNOSTICS LTD.
To: S.D. SIGHT DIAGNOSTICS LTD.
Reel/Frame 051939/0073 →